Browse > Article

Fibroblast Growth Factor 4 (FGF4) Expression in Malignant Skin Cancers  

Cho, Moon-Kyun (Department of Dermatology, College of Medicine, Soonchunhyang University)
Song, Woo-Jin (Department of Plastic and Reconstructive Surgery, College of Medicine, Soonchunhyang University)
Kim, Chul-Han (Department of Plastic and Reconstructive Surgery, College of Medicine, Soonchunhyang University)
Publication Information
Archives of Plastic Surgery / v.38, no.3, 2011 , pp. 217-221 More about this Journal
Abstract
Purpose: FGF4 (fibroblast growth factor 4) is a newly characterized gene which was found to be a transforming gene in several cancerous cells. FGF4 expression and amplification has been subsequently observed in several human cancers including stomach cancer, breast cancer, head and neck squamous cell carcinoma, lung cancer and bladder cancer. This study was designed to measure the protein expression of FGF4 in malignant skin cancers. Methods: We examined 8 normal skin tissues and 24 malignant skin tumor tissues which were 8 malignant melanomas, 8 squamous cell carcinomas and 8 basal cell carcinomas. The specimens were analyzed for the protein expression of FGF4 using immunohistochemical staining. To evaluate the amount of expression of FGF4, the histochemical score (HSCORE) was used. Results: FGF4 was expressed more intensely in malignant melanoma, followed by SCC and BCC in immunohistochemistry. The average HSCORE was 0.01 for normal skin, 2.02 for malignant melanoma, 1.28 for squamous cell carcinoma, and 0.27 for basal cell carcinoma, respectively. The expression of FGF4 in malignant melanoma and squamous cell carcinoma was increased in comparison with normal tissues and basal cell cancer, and the difference was statistically significant (p<0.05). The difference between malignant melanoma and squamous cell carcinoma was not statistically significant. Conclusion: These findings provide evidences that the expression of FGF4 plays an important role in malignant melanoma and squamous cell carcinoma progressions. This article demonstrates expression of FGF4 in human skin malignant tumors, and suggests that FGF4 is more expressed in highly aggressive skin tumors.
Keywords
FGF4; Skin cancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Yoshida T, Tsutsumi M, Sakamoto H, Miyagawa K, Teshima S, Sugimura T, Terada M: Expression of the HST1 oncogene in human germ cell tumors. Biochem Biophys Res Commun 155: 1324, 1988   DOI   ScienceOn
2 Park HS, Park CH, Choi BR, Lim MS, Heo SH, Kim CH, Kang SG, Whang KU, Cho MK: Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi. J Cutan Pathol 36: 511, 2009   DOI   ScienceOn
3 Powers CJ, McLeskey SW, Wellstein A: Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7: 165, 2000   DOI   ScienceOn
4 Auguste P, Gursel DB, Lemiere S, Reimers D, Cuevas P, Carceller F, Di Santo JP, Bikfalvi A: Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms. Cancer Res 61: 1717, 2001
5 Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD: Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306: 194, 1983   DOI   ScienceOn
6 Delli Bovi P, Basilico C: Isolation of a rearranged human transforming gene following transfection of Kaposi sarcoma DNA. Proc Natl Acad Sci 84: 5660, 1987   DOI   ScienceOn
7 Tsuda T, Nakatani H, Tahara E, Sakamoto H, Terada M, Sugimura T: HST1 and INT2 gene coamplification in a squamous cell carcinoma of the gallbladder. Jpn J Clin Oncol 19: 26, 1989
8 Muller D, Millon R, Lidereau R, Engelmann A, Bronner G, Flesch H, Eber M, Methlin G, Abecassis J: Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur J Cancer B Oral Oncol 30B: 113, 1994
9 Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y: DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 152: 1107, 1998
10 Hirai K, Sasaki H, Yamamoto H, Sakamoto H, Kubota Y, Kakizoe T, Terada M, Ochiya T: HST-1/FGF-4 protects male germ cells from apoptosis under heat-stress condition. Exp Cell Res 294: 77, 2004   DOI   ScienceOn
11 Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115, 1992
12 Shimon I, Hinton DR, Weiss MH, Melmed S: Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness. Clin Endocrinol 48: 23, 1998   DOI   ScienceOn
13 Kiuru-Kuhlefelt S, Sarlomo-Rikala M, Larramendy ML, Soderlund M, Hedman K, Miettinen M, Knuutila S: FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma. Mod Pathol 13: 433, 2000   DOI   ScienceOn
14 Hajitou A, Deroanne C, Noel A, Collette J, Nusgens B, Foidart JM, Calberg-Bacq CM: Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4. Breast Cancer Res Treat 60: 15, 2000   DOI   ScienceOn
15 Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I: A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol 130: 393, 1988